{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Tranexamic Acid in Surgically Treated Intracerebral Hemorrhage Patients"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "2325 participants with acute ICH were randomized"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized to receive either TXA or placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "investigates whether TXA reduces the frequency of neurosurgery and improves outcomes"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the frequency of neurosurgery within 7 days"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomization was computer-generated, and allocation was concealed"
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding included patients, clinicians, and outcome assessors"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "2325 participants with acute ICH were randomized"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The analysis was intention-to-treat"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "OR 0.893; 95% CI 0.619-1.289; P = .545"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events, including seizures, were more common"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ISRCTN93732214"
      },
      "Funding": {
        "score": 1,
        "evidence": "The trial was funded by the National Institute for Health Research"
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}